About: Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.74 (-3.33%)
TCRT NASDAQ Alaunos Therapeutics Inc
Alaunos Therapeutics Inc share price
TCRT price activity
Last Price
$1.740
Change (24hr)
-0.06 USD (3.33%)
Volume
1.48K
Volume (4w avg)
-
Previous Close
$1.80
Last Trade
05 Nov, 2:04 pm GMT+0
Delayed
05 Nov, 2:04 pm GMT+0
TCRT price performance
Delayed
05 Nov, 2:04 pm GMT+0
TCRT details
TCRT Market Signals